Cai, L., Duan, J., Qian, L., Wang, Z., Wang, S., Li, S., . . . Wang, J. (2020). ROS1 Fusion Mediates Immunogenicity by Upregulation of PD-L1 After the Activation of ROS1–SHP2 Signaling Pathway in Non-Small Cell Lung Cancer. Front Immunol.
Chicago-стиль цитированияCai, Liangliang, et al. "ROS1 Fusion Mediates Immunogenicity By Upregulation of PD-L1 After the Activation of ROS1–SHP2 Signaling Pathway in Non-Small Cell Lung Cancer." Front Immunol 2020.
MLA-цитированиеCai, Liangliang, et al. "ROS1 Fusion Mediates Immunogenicity By Upregulation of PD-L1 After the Activation of ROS1–SHP2 Signaling Pathway in Non-Small Cell Lung Cancer." Front Immunol 2020.
Предупреждение: эти цитированмия не могут быть всегда правильны на 100%.